Table 3-5 Endovascular treatment for chronic lower limb ischemia*14).
Endovascular treatment | Cases | Gender | Mortality | Dialysis cases | Etiology | ||||
---|---|---|---|---|---|---|---|---|---|
Male | Female | 30-day mortality | Hospital mortality | ASO | TAO | Others | |||
Aorto–iliac lesion*21) | 2,922 | 1,399 | 523 | 31 | 41 | 357 | 1,884 | 3 | 35 |
Femoro–popliteal lesion*21) | 2,436 | 1,706 | 730 | 23 | 44 | 650 | 2,421 | 4 | 11 |
Infrapopliteal–ankle lesion*21) | 1,277 | 848 | 428 | 19 | 47 | 584 | 1,262 | 7 | 8 |
Others | 57 | 39 | 18 | 0 | 0 | 20 | 50 | 1 | 6 |
Total (number of regions underwent EVT)*21) | 5,792 | 4,336 | 1,455 | 59 | 106 | 1,318 | 5,727 | 12 | 53 |
Total (number of limbs underwent EVT)*22) | 4,944 | 3,719 | 1,224 | 46 | 83 | 1,046 | 4,889 | 9 | 46 |
*10) Bypass surgery combined with endovascular treatment is counted in both bypass category (Table 3-2) and endovascular category (Table 3-5). *11) Including redo operation only. Revision surgery cases should be counted in vascular complication part (see Table 6). *12) Including collagen disease related vasculitis, Behçet disease, fibromuscular dysplasia. *13) Postoperative irreversible brain complication. *14) Including percutaneous transluminal angioplasty (PTA), stent, and other endovascular means such as catheter atherectomy. *15) Only for open surgery. *16) Including aorto–iliac bypass or ilio–femoral bypasses. *17) Including popliteal–crural (or pedal) bypass. *18) Cases underwent extraanatomic bypass because of graft infection should not be included in this category. Those cases are listed in vascular complication (Table 6). *19) A case underwent axillo–femoro–femoral crossover bypass is counted as on case. A case combined with additional contralateral side of axillilo–femoral bypass as second staged surgery is counted as 2 cases. *20) Including patch plasty. *21) When endovascular treatment performed for multiple region, the case should be counted in each region (If a case underwent endovascular treatment in both aorto–iliac and femoro–popliteal region, this case can be counted one in aorto–iliac, and one in femoro–popliteal region). *22) Counting the patients number. When a case underwent endovascular treatment in multiple regions, the case is counted as one case. Abbreviations; ASO: arteriosclerosis obriterance, TAO: thromboangiitis obliterans (Buerger’s disease), CAS: carotid artery stenting, CEA: carotid endarterectomy, PTA: percutaneous transluminal angioplasty, EVT: endovascular treatment, IIA: internal iliac artery